FDA orphan drug designation: treatment of amyotrophic lateral sclerosis
All entries for: Mitsubishi Tanabe Pharma America Inc.
August 7, 2025
Mitsubishi Tanabe Pharma America Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
